Chinese Journal of Modern Operative Surgery 2017, Vol. 21 Issue (1): 27-30 DOI: 10.16260/j.cnki.1009-2188.2017.01.007 |
Clinical Research |
|
|
|
|
|
Observation of Clinical Effect and Postoperative Complications of Videoassisted Thoracoscopic Surgery in Patients with Esophageal Carcinoma |
LI Xiaolei, XU Jun, LIANG Qingsong, CHEN Xu
|
Department of Thoracic Surgery, Nanchong Central Hospital, Nanchong 637000, Sichuan, China |
|
|
Abstract ObjectiveTo observe the clinical effect and postoperative complications in patients with esophageal carcinoma treated by videoassisted thoracoscopic surgery.MethodsFrom August 2014 to September 2016, 92 cases of esophageal carcinoma were treated in our hospital. The patients were divided into the observation group and the control group, with 46 patients in each group. The observation group was treated with videoassisted thoracoscopic surgery. And the control group was treated with open esophagectomy. The operation indexes, pulmonary function and postoperative complications were compared between the two groups.ResultsOperation time of the observation group was significantly longer than that of the control group (P<0.05); The amount of intraoperative bleeding, postoperative drainage, extubation time and postoperative ambulation time of the observation group was significantly better than that of the control group (P<0.05). There was no significant difference between the groups in the number of dissected lymph nodes (P>0.05). The VC% and FEV1% of the observation group was significantly better than that of the control group (P<0.05). But there was no significant difference in FEV%, FVC% and MVV% between the two groups (P>0.05). The postoperative complication rate of the observation group and the control group was 15.22% (7/46) and 43.48% (20/46) respectively; which showed obvious superiority of the observation group (P<0.05).ConclusionComparing with traditional open chest surgery, it is recommended of the thoracoscopic radical resection for esophageal carcinoma patients for the advantages of less trauma, quicker recovery and less postoperative complication rate.
|
Published: 25 May 2018
|
|
Corresponding Authors:
XU Jun
|
|
|
|
Essadi I, Lalya I, Mansouri H. Esophageal carcinoma[J]. N Engl J Med, 2015,372(15):14701471. doi: 10.1056/NEJMc1500692#SA1.
|
[2] |
乔友林. 食管癌流行病学研究的重要里程碑[J]. 中国肿瘤临床, 2016, 43(12):500501.
|
[3] |
金虎日, 车成日. 电视胸腹腔镜下与传统开胸手术治疗食管癌的疗效对比分析[J]. 重庆医学, 2014,43(14):17271728.
|
[4] |
Hoffmann AC, Vallbhmer D, Grimminger P, et al. Preoperative survivin mRNA detection in peripheral blood is an independent predictor ofoutcome in esophageal carcinoma[J]. Pharmacogenomics, 2010,11(3):341347. doi: 10.2217/pgs.09.164.
|
[5] |
Guo HM, Zhang XQ, Chen M, et al. Endoscopic submucosal dissection vs endoscopic mucosal resection for superficial esophagealcancer[J]. World J Gastroenterol, 2014,20(18):55405547. doi: 10.3748/wjg.v20.i18.5540.
|
[6] |
左婷婷, 郑荣寿, 曾红梅,等. 中国食管癌发病状况与趋势分析[J]. 中华肿瘤杂志, 2016, 38(9):703708.
|
[7] |
Napier KJ, Scheerer M, Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatmentmodalities[J]. World J Gastrointest Oncol, 2014,6(5):112120. doi: 10.4251/wjgo.v6.i5.112.
|
[8] |
Chen W, Zheng R, Zhang S, et al. Esophageal cancer incidence and mortality in China, 2010[J]. Thorac Cancer, 2014,5(4):343348. doi: 10.1111/17597714.12100.
|
[9] |
凌建华. 胸腔镜与开胸手术治疗早期食管癌的临床疗效观察[J]. 四川医学, 2014(5):569571.
|
[10] |
王晓骏, 张铸, 孙清超. 胸腹腔镜联合下食管癌切除术与开放手术疗效对比的Meta分析[J]. 世界华人消化杂志,2014, 22(3): 375382.
|
[11] |
Domper Arnal MJ, Ferrández Arenas , Lanas Arbeloa . Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Easterncountries[J]. World J Gastroenterol, 2015,21(26):79337943. doi: 10.3748/wjg.v21.i26.7933.
|
[12] |
Gao Y, Wang Y, Chen L, et al. Comparison of open threefield and minimallyinvasive esophagectomy for esophageal cancer[J]. Interact Cardiovasc Thorac Surg, 2011,12(3):366369. doi: 10.1510/icvts.2010.258632.
|
[13] |
Ye K, Xu JH, Sun YF, et al. Characteristics and clinical significance of lymph node metastases near the recurrent laryngealnerve from thoracic esophageal carcinoma[J]. Genet Mol Res, 2014,13(3):64116419. doi: 10.4238/2014.August.25.4.
|
|
|
|